Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| AMGEN INCAMGN · Entity 2832 | EVP, Global Commercial Ops. | May 03, 2018 | May 07, 2018 |
| BRISTOL MYERS SQUIBB COBMY · Entity 1662 | SVP ComOps Pres USJap Int | May 13, 2011 | May 17, 2011 |
| BeOne Medicines Ltd.ONC · Entity 2168 | Director | June 11, 2026 | June 15, 2026 |
| MANNKIND CORPMNKD · Entity 4792 | Director | May 20, 2026 | May 23, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
AMGEN INC
Report date May 03, 2018 · Filed May 07, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 215,147 |
Reported balance
After 2018-05-03 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2018-05-03 · Tax withholding · Disposed 883 · Balance 215,147 F1: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 1,563 RSUs which vest in one installment on 1/30/2019; 3,428 RSUs which vest in installments of 1,688 on 5/3/2019 and 1,740 on 5/3/2020; and 4,920 RSUs which vest in installments of 1,623 on 5/1/2019, 1,624 on 5/1/2020 and 1,673 on 5/1/2021. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. F2: These shares include 449 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount. |
Filing footnotes · ownership attribution and instrument terms
F1: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 1,563 RSUs which vest in one installment on 1/30/2019; 3,428 RSUs which vest in installments of 1,688 on 5/3/2019 and 1,740 on 5/3/2020; and 4,920 RSUs which vest in installments of 1,623 on 5/1/2019, 1,624 on 5/1/2020 and 1,673 on 5/1/2021. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis.
F2: These shares include 449 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.
BRISTOL MYERS SQUIBB CO
Report date May 13, 2011 · Filed May 17, 2011
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, $0.10 par valueSEC Table I · non-derivative | Direct | 203,170 |
Ending reported balance
After 2011-05-13 transaction · row 4
4 source rows · reconciled sequenceRow 1 · 2011-05-13 · Exercise / conversion · Acquired 381,750 · Balance 544,178 Row 2 · 2011-05-13 · Sale · Disposed 13,372 · Balance 530,806 F1: This transaction was executed in multiple trades from $28.7500 to $28.8550. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Row 3 · 2011-05-13 · Tax withholding · Disposed 47,869 · Balance 482,937 F2: Shares withheld for payment of taxes and fees upon exercise of stock options. F1: This transaction was executed in multiple trades from $28.7500 to $28.8550. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Row 4 · 2011-05-13 · Tax withholding · Disposed 279,767 · Balance 203,170 F3: Shares withheld for payment of exercise price upon exercise of stock options. F1: This transaction was executed in multiple trades from $28.7500 to $28.8550. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| Executive Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $17.51 · Expires 2019-03-02 | Direct | 158,634 |
Reported balance
After 2011-05-13 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2011-05-13 · Exercise / conversion · Disposed 110,000 · Balance 158,634 F5: Twenty-five percent of the stock option award vests on each of the first, second, third and fourth anniversaries of the grant date. |
| Executive Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $22.14 · Expires 2018-03-03 | Direct | 46,495 |
Reported balance
After 2011-05-13 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2011-05-13 · Exercise / conversion · Disposed 125,000 · Balance 46,495 F5: Twenty-five percent of the stock option award vests on each of the first, second, third and fourth anniversaries of the grant date. |
| Executive Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $22.73 · Expires 2016-03-06 | Direct | 0 |
Reported balance
After 2011-05-13 transaction · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · 2011-05-13 · Exercise / conversion · Disposed 78,750 · Balance 0 F6: Currently exercisable. |
| Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $23.14 · Expires 2013-03-03 | Direct | 0 |
Reported balance
After 2011-05-13 transaction · row 10
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 10 · 2011-05-13 · Exercise / conversion · Disposed 68,000 · Balance 0 F6: Currently exercisable. |
| Common Stock, $0.10 par valueSEC Table I · non-derivative | IndirectBy BMY Savings & Investment Program | 1,573.97 |
Reported balance
Holding disclosure · report date 2011-05-13 · row 5
Holding and transaction disclosures are not merged.
1 source rowRow 5 · Balance 1,573.97 F4: Based on a plan statement as of the end of the most recent fiscal quarter. |
| Common Stock, $0.10 par valueSEC Table I · non-derivative | IndirectBy Spouse | 3,675 |
Reported balance
Holding disclosure · report date 2011-05-13 · row 6
Holding and transaction disclosures are not merged.
1 source rowRow 6 · Balance 3,675 |
Filing footnotes · ownership attribution and instrument terms
F1: This transaction was executed in multiple trades from $28.7500 to $28.8550. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F2: Shares withheld for payment of taxes and fees upon exercise of stock options.
F3: Shares withheld for payment of exercise price upon exercise of stock options.
F4: Based on a plan statement as of the end of the most recent fiscal quarter.
F5: Twenty-five percent of the stock option award vests on each of the first, second, third and fourth anniversaries of the grant date.
F6: Currently exercisable.
BeOne Medicines Ltd.
Report date June 11, 2026 · Filed June 15, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary SharesSEC Table I · non-derivative | Direct | 83,720 |
Reported balance
After 2026-06-11 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-06-11 · Grant · Acquired 18,980 · Balance 83,720 F1: Represents securities underlying restricted share units. The restricted share units shall become fully vested on the earlier to occur of the first anniversary of the grant date or the date of the next annual general meeting; provided, however, that all vesting shall cease if the director resigns from the board of directors or otherwise ceases to serve as a director, unless there is a triggering event of accelerated vesting pursuant to the Company's Independent Non-Executive Director Compensation Policy. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents securities underlying restricted share units. The restricted share units shall become fully vested on the earlier to occur of the first anniversary of the grant date or the date of the next annual general meeting; provided, however, that all vesting shall cease if the director resigns from the board of directors or otherwise ceases to serve as a director, unless there is a triggering event of accelerated vesting pursuant to the Company's Independent Non-Executive Director Compensation Policy.
MANNKIND CORP
Report date May 20, 2026 · Filed May 23, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Stock UnitSEC Table II · derivative / convertible security | Direct | 82,781 |
Reported balance
After 2026-05-20 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-05-20 · Grant · Acquired 82,781 · Balance 82,781 F1: Each restricted stock unit represents a contingent right to receive one share of MNKD common stock. F2: Restricted stock unit vested on May 20, 2026, but the shares will not be delivered until there is a separation of service from the board of directors of MannKind Corporation. |
| Restricted Stock UnitSEC Table II · derivative / convertible security | Direct | 16,556 |
Reported balance
After 2026-05-20 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-05-20 · Grant · Acquired 16,556 · Balance 16,556 F1: Each restricted stock unit represents a contingent right to receive one share of MNKD common stock. F3: Award granted in lieu of annual cash retainer payment for non-employee directors. Restricted stock unit shall vest immediately, but the shares shall not be delivered until there is a separation of service from the board of directors of MannKind Corporation. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit represents a contingent right to receive one share of MNKD common stock.
F2: Restricted stock unit vested on May 20, 2026, but the shares will not be delivered until there is a separation of service from the board of directors of MannKind Corporation.
F3: Award granted in lieu of annual cash retainer payment for non-employee directors. Restricted stock unit shall vest immediately, but the shares shall not be delivered until there is a separation of service from the board of directors of MannKind Corporation.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 01, 2011 Filed Mar 4, 2011 02:56 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Tax withholdingCommon Stock, $0.10 par value | 19,272 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-11-008703 · doc4.xml · nonDerivative · entry 3 HOOPER ANTHONY C · CIK 0001277244 · SVPComOps PresUSJapInterc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 153,374 F3 · shares: Shares withheld for payment of taxes upon payout of the 2008-2010 special long-term performance award. Read SEC document |
| March 01, 2011 Filed Mar 4, 2011 02:56 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Tax withholdingCommon Stock, $0.10 par value | 12,328 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-11-008703 · doc4.xml · nonDerivative · entry 2 HOOPER ANTHONY C · CIK 0001277244 · SVPComOps PresUSJapInterc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 172,646 F2 · shares: Shares withheld for payment of taxes upon payout of the 2008-2010 regular long-term performance award. Read SEC document |
| March 01, 2011 Filed Mar 4, 2011 02:56 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Exercise / conversionCommon Stock, $0.10 par value | 76,455 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-11-008703 · doc4.xml · nonDerivative · entry 1 HOOPER ANTHONY C · CIK 0001277244 · SVPComOps PresUSJapInterc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 184,974 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Consists of performance shares earned under the 2008-2010 Regular Long-Term Performance Award and the 2008-2010 Special Long-Term Performance Award. Read SEC document |
| March 01, 2011 Filed Mar 16, 2011 20:31 UTC Amendment | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Tax withholdingCommon Stock, $0.10 par value | 19,272 | $25.58 | $492,977.76 |
DisclosureSEC source: 0001225208-11-009848 · doc4a.xml · nonDerivative · entry 2 HOOPER ANTHONY C · CIK 0001277244 · SVP ComOps Pres USJap Int 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 153,374 F3 · shares: This Form 4 is amended to report the correct price for the shares withheld for the payment of taxes upon payout of the 2008-2010 special long-term performance award. F2 · balance_after: Includes unvested restricted stock awards. Read SEC document |
| March 01, 2011 Filed Mar 16, 2011 20:31 UTC Amendment | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Tax withholdingCommon Stock, $0.10 par value | 12,328 | $25.58 | $315,350.24 |
DisclosureSEC source: 0001225208-11-009848 · doc4a.xml · nonDerivative · entry 1 HOOPER ANTHONY C · CIK 0001277244 · SVP ComOps Pres USJap Int 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 172,646 F1 · shares: This Form 4 is amended to report the correct price for the shares withheld for payment of taxes upon payout of the 2008-2010 regular long-term performance award. F2 · balance_after: Includes unvested restricted stock awards. Read SEC document |
| September 20, 2010 Filed Sep 22, 2010 18:38 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Tax withholdingCommon Stock, $0.10 par value | 3,863 | $27.81 | $107,430.03 |
DisclosureSEC source: 0001225208-10-021241 · doc4.xml · nonDerivative · entry 1 HOOPER ANTHONY C · CIK 0001277244 · SVPComOps PresUSJapInterc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,519 F1 · shares: Shares withheld for payment of taxes upon vesting of restricted stock. F2 · balance_after: Includes unvested restricted stock awards. Read SEC document |
| May 03, 2010 Filed May 5, 2010 19:45 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | GrantRestricted Stock Units · Derivative | 20,113 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-10-012118 · doc4.xml · derivative · entry 1 HOOPER ANTHONY C · CIK 0001277244 · President Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,012 Underlying: Common Stock, $0.10 par value · 20,113 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit converts into one share of common stock upon vesting. F2 · derivative.exercise_date: One-third of the restricted stock units will vest on each of the third, fourth and fifth anniversaries of the grant date and be converted into shares of common stock. F2 · derivative.expiration_date: One-third of the restricted stock units will vest on each of the third, fourth and fifth anniversaries of the grant date and be converted into shares of common stock. Read SEC document |
| March 07, 2010 Filed Mar 10, 2010 01:22 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Tax withholdingCommon Stock, $0.10 par value | 2,921 | $24.60 | $71,856.60 |
DisclosureSEC source: 0001225208-10-007596 · doc4.xml · nonDerivative · entry 3 HOOPER ANTHONY C · CIK 0001277244 · President Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,382 F3 · shares: Shares withheld for payment of taxes upon vesting of restricted stock. F1 · balance_after: Includes unvested restricted stock awards. Read SEC document |
| March 06, 2010 Filed Mar 10, 2010 01:22 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Exercise / conversionRestricted Stock Units · Derivative | 8,717 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001225208-10-007596 · doc4.xml · derivative · entry 6 HOOPER ANTHONY C · CIK 0001277244 · President Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,899 Underlying: Common Stock, $0.10 par value · 8,717 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: Each restricted stock unit converts into one share of common stock upon vesting. F6 · derivative.exercise_date: One-third of the restricted stock units will vest on each of the third, fourth and fifth anniversaries of the grant date and be converted into shares of common stock. F6 · derivative.expiration_date: One-third of the restricted stock units will vest on each of the third, fourth and fifth anniversaries of the grant date and be converted into shares of common stock. Read SEC document |
| March 06, 2010 Filed Mar 10, 2010 01:22 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Tax withholdingCommon Stock, $0.10 par value | 4,041 | $24.60 | $99,408.60 |
DisclosureSEC source: 0001225208-10-007596 · doc4.xml · nonDerivative · entry 2 HOOPER ANTHONY C · CIK 0001277244 · President Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 115,303 F2 · shares: Shares withheld for payment of taxes upon vesting of restricted stock units. F1 · balance_after: Includes unvested restricted stock awards. Read SEC document |
| March 06, 2010 Filed Mar 10, 2010 01:22 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Exercise / conversionCommon Stock, $0.10 par value | 8,717 | $24.60 | $214,438.20 |
DisclosureSEC source: 0001225208-10-007596 · doc4.xml · nonDerivative · entry 1 HOOPER ANTHONY C · CIK 0001277244 · President Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,344 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes unvested restricted stock awards. Read SEC document |
| March 02, 2010 Filed Mar 4, 2010 23:57 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Exercise / conversionPerformance Shares · Derivative | 37,233 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001225208-10-007219 · doc4.xml · derivative · entry 9 HOOPER ANTHONY C · CIK 0001277244 · President Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,707 Underlying: Common Stock, $0.10 par value · 37,233 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F10 · derivative.exercise_price: Each performance share converts into one share of common stock upon distribution in the first quarter of 2010. F10 · derivative.exercise_date: Each performance share converts into one share of common stock upon distribution in the first quarter of 2010. F10 · derivative.expiration_date: Each performance share converts into one share of common stock upon distribution in the first quarter of 2010. Read SEC document |
| March 02, 2010 Filed Mar 4, 2010 23:57 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | GrantPerformance Shares · Derivative | 11,863 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001225208-10-007219 · doc4.xml · derivative · entry 8 HOOPER ANTHONY C · CIK 0001277244 · President Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,940 Underlying: Common Stock, $0.10 par value · 11,863 shares Expires not disclosed F10 · derivative.exercise_price: Each performance share converts into one share of common stock upon distribution in the first quarter of 2010. F11 · shares: Consists of performance shares earned under the 2007-2009 Long-Term Performance Award. F10 · derivative.exercise_date: Each performance share converts into one share of common stock upon distribution in the first quarter of 2010. F10 · derivative.expiration_date: Each performance share converts into one share of common stock upon distribution in the first quarter of 2010. Read SEC document |
| March 02, 2010 Filed Mar 4, 2010 23:57 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | GrantPerformance Shares · Derivative | 22,270 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001225208-10-007219 · doc4.xml · derivative · entry 7 HOOPER ANTHONY C · CIK 0001277244 · President Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 101,077 Underlying: Common Stock, $0.10 par value · 22,270 shares Expires not disclosed F8 · derivative.exercise_price: Each performance share converts into one share of common stock upon distribution in the first quarter of 2012. F9 · shares: Consists of performance shares earned under the 2009-2011 Long-Term Performance Award. F8 · derivative.exercise_date: Each performance share converts into one share of common stock upon distribution in the first quarter of 2012. F8 · derivative.expiration_date: Each performance share converts into one share of common stock upon distribution in the first quarter of 2012. Read SEC document |
| March 02, 2010 Filed Mar 4, 2010 23:57 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | GrantPerformance Shares · Derivative | 25,889 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001225208-10-007219 · doc4.xml · derivative · entry 6 HOOPER ANTHONY C · CIK 0001277244 · President Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,807 Underlying: Common Stock, $0.10 par value · 25,889 shares Expires not disclosed F6 · derivative.exercise_price: Each performance share converts into one share of common stock upon distribution in the first quarter of 2011. F7 · shares: Consists of performance shares earned under the 2008-2010 Regular Long-Term Performance Award and the 2008-2010 Special Long-Term Performance Award. F6 · derivative.exercise_date: Each performance share converts into one share of common stock upon distribution in the first quarter of 2011. F6 · derivative.expiration_date: Each performance share converts into one share of common stock upon distribution in the first quarter of 2011. Read SEC document |
| March 02, 2010 Filed Mar 4, 2010 23:57 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | GrantMarket Share Units · Derivative | 35,684 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001225208-10-007219 · doc4.xml · derivative · entry 5 HOOPER ANTHONY C · CIK 0001277244 · President Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,684 Underlying: Common Stock, $0.10 par value · 35,684 shares Expires not disclosed F4 · derivative.exercise_price: Each market share unit converts into the number of shares of common stock based on the average of the closing share price of the company?s common stock on the vesting date and the nine trading days immediately preceding the vesting date. F5 · derivative.exercise_date: Twenty-five percent of the market share unit award will vest on each of the first, second, third and fourth anniversaries of the grant date and will be converted into shares of common stock based on a conversion factor. F5 · derivative.expiration_date: Twenty-five percent of the market share unit award will vest on each of the first, second, third and fourth anniversaries of the grant date and will be converted into shares of common stock based on a conversion factor. Read SEC document |
| March 02, 2010 Filed Mar 4, 2010 23:57 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Tax withholdingCommon Stock, $0.10 par value | 17,259 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-10-007219 · doc4.xml · nonDerivative · entry 2 HOOPER ANTHONY C · CIK 0001277244 · President Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,627 F2 · shares: Withheld for the payment of taxes upon payout of shares under a Long-Term Performance Award. Read SEC document |
| March 02, 2010 Filed Mar 4, 2010 23:57 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Exercise / conversionCommon Stock, $0.10 par value | 37,233 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-10-007219 · doc4.xml · nonDerivative · entry 1 HOOPER ANTHONY C · CIK 0001277244 · President Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 127,886 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Consists of shares earned as long-term performance awards under the 2002 Stock Incentive Plan. Read SEC document |
| March 01, 2010 Filed Mar 3, 2010 21:25 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Tax withholdingCommon Stock, $0.10 par value | 1,100 | $24.57 | $27,027.00 |
DisclosureSEC source: 0001225208-10-006843 · doc4.xml · nonDerivative · entry 1 HOOPER ANTHONY C · CIK 0001277244 · President Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,653 F1 · shares: Shares withheld for payment of taxes upon vesting of restricted stock. F2 · balance_after: Includes unvested restricted stock awards. Read SEC document |
| December 23, 2009 Filed Dec 28, 2009 18:57 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | OtherCommon Stock, $0.10 par value | 1,720 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-09-025008 · doc4.xml · nonDerivative · entry 2 HOOPER ANTHONY C · CIK 0001277244 · President Americas 10b5-1 filing: Not disclosed Ownership: Indirect · By BMY Savings & Investment Program Disclosed balance after: 1,450.83 F3 · shares: The reporting person directed the Trustee of the Savings and Investment Plan to exchange 1,720 shares of BMS held in the Bristol-Myers Squibb Company Stock Fund into 1,085 shares of MJN to be invested in a new Mead Johnson Nutrition Company Stock Fund. F4 · balance_after: Based on a plan statement as of the end of the most recent fiscal quarter. Read SEC document |
| December 23, 2009 Filed Dec 28, 2009 18:57 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | SaleCommon Stock, $0.10 par value | 8,084 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-09-025008 · doc4.xml · nonDerivative · entry 1 HOOPER ANTHONY C · CIK 0001277244 · President Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,753 F1 · shares: The reporting person exchanged 8,084 shares of Bristol-Myers Squibb common stock for 5,103 shares of Mead Johnson Nutrition Company common stock in an issuer exchange offer. F2 · balance_after: Includes unvested restricted stock awards. Read SEC document |
| September 21, 2009 Filed Sep 22, 2009 17:54 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Tax withholdingCommon Stock, $0.10 par value | 3,871 | $22.52 | $87,174.92 |
DisclosureSEC source: 0001225208-09-019169 · doc4.xml · nonDerivative · entry 1 HOOPER ANTHONY C · CIK 0001277244 · President Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,837 F1 · shares: Shares withheld for payment of taxes upon vesting of restricted stock. F2 · balance_after: Includes unvested restricted stock awards. Read SEC document |
| March 06, 2009 Filed Mar 10, 2009 22:05 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Tax withholdingCommon Stock, $0.10 par value | 2,297 | $18.35 | $42,149.95 |
DisclosureSEC source: 0001225208-09-006767 · doc4.xml · nonDerivative · entry 1 HOOPER ANTHONY C · CIK 0001277244 · President Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 115,707 F1 · shares: Shares withheld for payment of taxes upon vesting of restricted stock. F2 · balance_after: Includes unvested restricted stock awards. Read SEC document |
| March 03, 2009 Filed Mar 5, 2009 22:12 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | GrantRestricted Stock Units · Derivative | 22,616 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001225208-09-006377 · doc4.xml · derivative · entry 2 HOOPER ANTHONY C · CIK 0001277244 · President Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,616 Underlying: Common Stock, $0.10 par value · 22,616 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit converts into one share of common stock upon vesting. F3 · derivative.exercise_date: One-third of the restricted stock units will vest on each of the third, fourth and fifth anniversaries of the grant date and be converted into shares of common stock. F3 · derivative.expiration_date: One-third of the restricted stock units will vest on each of the third, fourth and fifth anniversaries of the grant date and be converted into shares of common stock. Read SEC document |
| March 03, 2009 Filed Mar 5, 2009 22:12 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | GrantExecutive Option (right to buy) · Derivative | 268,634 | $0.00 Strike: $17.51 | $0.00 |
DisclosureSEC source: 0001225208-09-006377 · doc4.xml · derivative · entry 1 HOOPER ANTHONY C · CIK 0001277244 · President Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 268,634 Underlying: Common Stock, $0.10 par value · 268,634 shares Expires 2019-03-02 F1 · derivative.exercise_date: Option is not exercisable until the closing share price of common stock achieves a price of at least 15% above the option grant price and remains at that price for seven consecutive trading days. Option vests 25% of the shares annually, on a cumulative basis, commencing one year after the date of grant, but may not be exercised until the threshold is satisfied. Read SEC document |
| March 03, 2009 Filed Jan 14, 2011 21:14 UTC Amendment | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | GrantRestricted Stock Units · Derivative | 18,778 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-11-003098 · doc4a.xml · derivative · entry 1 HOOPER ANTHONY C · CIK 0001277244 · SVPComOps PresUSJapInterc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,778 Underlying: Common Stock, $0.10 par value · 18,778 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit converts into one share of common stock upon vesting. F2 · shares: This Form 4 is being amended to reflect the correct number of restricted stock units awarded to Mr. Hooper. F3 · derivative.exercise_date: One-third of the restricted stock units will vest on each of the third, fourth and fifth anniversaries of the grant date and be converted into shares of common stock. F3 · derivative.expiration_date: One-third of the restricted stock units will vest on each of the third, fourth and fifth anniversaries of the grant date and be converted into shares of common stock. Read SEC document |
| March 02, 2009 Filed Mar 3, 2009 22:15 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Tax withholdingCommon Stock, $0.10 par value | 1,283 | $17.74 | $22,760.42 |
DisclosureSEC source: 0001225208-09-005821 · doc4.xml · nonDerivative · entry 2 HOOPER ANTHONY C · CIK 0001277244 · President US Pharmaceuticals 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 118,004 F1 · shares: Shares withheld for payment of taxes upon vesting of restricted stock. F2 · balance_after: Includes unvested restricted stock awards. Read SEC document |
| March 01, 2009 Filed Mar 3, 2009 22:15 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Tax withholdingCommon Stock, $0.10 par value | 1,131 | $18.41 | $20,821.71 |
DisclosureSEC source: 0001225208-09-005821 · doc4.xml · nonDerivative · entry 1 HOOPER ANTHONY C · CIK 0001277244 · President US Pharmaceuticals 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,287 F1 · shares: Shares withheld for payment of taxes upon vesting of restricted stock. F2 · balance_after: Includes unvested restricted stock awards. Read SEC document |
| February 19, 2009 Filed Feb 23, 2009 21:20 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | GrantPerformance Shares · Derivative | 13,803 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001225208-09-004536 · doc4.xml · derivative · entry 5 HOOPER ANTHONY C · CIK 0001277244 · President US Pharmaceuticals 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,918 Underlying: Common Stock, $0.10 par value · 13,803 shares Expires not disclosed F6 · derivative.exercise_price: Each performance share is converted into one share of common stock upon distribution in the first quarter of 2010. F7 · shares: Consists of performance shares earned under the 2007-2009 Long-Term Performance Award. F6 · derivative.exercise_date: Each performance share is converted into one share of common stock upon distribution in the first quarter of 2010. F6 · derivative.expiration_date: Each performance share is converted into one share of common stock upon distribution in the first quarter of 2010. Read SEC document |
| February 19, 2009 Filed Feb 23, 2009 21:20 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | GrantPerformance Shares · Derivative | 27,548 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001225208-09-004536 · doc4.xml · derivative · entry 4 HOOPER ANTHONY C · CIK 0001277244 · President US Pharmaceuticals 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,115 Underlying: Common Stock, $0.10 par value · 27,548 shares Expires not disclosed F4 · derivative.exercise_price: Each performance share is converted into one share of common stock upon distribution in the first quarter of 2011. F5 · shares: Consists of performance shares earned under the 2008-2010 Regular Long-Term Performance Award and the 2008-2010 Special Long-Term Performance Award. F4 · derivative.exercise_date: Each performance share is converted into one share of common stock upon distribution in the first quarter of 2011. F4 · derivative.expiration_date: Each performance share is converted into one share of common stock upon distribution in the first quarter of 2011. Read SEC document |
| February 19, 2009 Filed Feb 23, 2009 21:20 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | GrantCommon Stock, $0.10 par value | 25,830 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-09-004536 · doc4.xml · nonDerivative · entry 1 HOOPER ANTHONY C · CIK 0001277244 · President US Pharmaceuticals 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,418 F1 · shares: Consists of shares earned as long-term performance awards under the 2002 Stock Incentive Plan. F2 · balance_after: Includes unvested restricted stock awards. Read SEC document |
| February 19, 2009 Filed Mar 24, 2009 19:43 UTC Amendment | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Tax withholdingCommon Stock, $0.10 par value | 11,999 | $20.51 | $246,099.49 |
DisclosureSEC source: 0001225208-09-007614 · doc4a.xml · nonDerivative · entry 1 HOOPER ANTHONY C · CIK 0001277244 · President Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,419 F1 · kind: This Form 4 is being amended to reflect the shares withheld for taxes upon the distribution of a performance share award. F2 · shares: Shares withheld for payment of taxes upon distribution of long-term performance award. F3 · balance_after: Includes unvested restricted stock awards. Read SEC document |
| September 19, 2008 Filed Sep 23, 2008 20:02 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Tax withholdingCommon Stock, $0.10 par value | 3,871 | $21.00 | $81,291.00 |
DisclosureSEC source: 0001225208-08-015044 · doc4.xml · nonDerivative · entry 1 HOOPER ANTHONY C · CIK 0001277244 · President US Pharmaceuticals 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94,588 F1 · shares: Shares withheld for payment of taxes upon vesting of restricted stock. F2 · balance_after: Includes unvested restricted stock awards. Read SEC document |
| September 10, 2008 Filed Sep 12, 2008 18:30 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Tax withholdingCommon Stock, $0.10 par value | 3,872 | $21.67 | $83,906.24 |
DisclosureSEC source: 0001225208-08-014721 · doc4.xml · nonDerivative · entry 1 HOOPER ANTHONY C · CIK 0001277244 · President US Pharmaceuticals 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,459 F1 · shares: Shares withheld for payment of taxes upon vesting of restricted stock. F2 · balance_after: Includes unvested restricted stock awards. Read SEC document |
| March 04, 2008 Filed Mar 6, 2008 22:03 UTC | BRISTOL MYERS SQUIBB CO (BMY) · Entity 1662 | GrantRestricted Stock Units · Derivative | 13,077 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-08-000097 · hoo838.xml · derivative · entry 2 HOOPER ANTHONY C · CIK 0001277244 · President US Pharmaceuticals 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,077 Underlying: Common Stock, $0.10 par value · 13,077 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit converts into one share of common stock upon vesting. F3 · derivative.exercise_date: One-third of the restricted stock units will vest on each of the third, fourth and fifth anniversaries of the grant date and be converted into shares of common stock. F3 · derivative.expiration_date: One-third of the restricted stock units will vest on each of the third, fourth and fifth anniversaries of the grant date and be converted into shares of common stock. Read SEC document |
| March 04, 2008 Filed Mar 6, 2008 22:03 UTC | BRISTOL MYERS SQUIBB CO (BMY) · Entity 1662 | GrantExecutive Option (right to buy) · Derivative | 171,495 | $0.00 Strike: $22.14 | $0.00 |
DisclosureSEC source: 0000014272-08-000097 · hoo838.xml · derivative · entry 1 HOOPER ANTHONY C · CIK 0001277244 · President US Pharmaceuticals 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 171,495 Underlying: Common Stock, $0.10 par value · 171,495 shares Expires 2018-03-03 F1 · derivative.exercise_date: Option is not exercisable until the closing share price of common stock achieves a price of at least 15% above the option grant price and remains at that price for seven consecutive trading days. Shares vest 25% per year, on a cumulative basis, commencing one year after the grant date. Read SEC document |
| March 04, 2008 Filed Feb 17, 2009 23:51 UTC Amendment | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | GrantPerformance Shares · Derivative | 11,567 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-09-000013 · primary_doc.xml · derivative · entry 1 HOOPER ANTHONY C · CIK 0001277244 · President US Pharmaceuticals 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,567 Underlying: Common Stock $0.10 par value · 11,567 shares Expires not disclosed F1 · derivative.exercise_price: (1) Each performance share converts into one share of common stock upon distribution during the first quarter of 2010. F1 · derivative.exercise_date: (1) Each performance share converts into one share of common stock upon distribution during the first quarter of 2010. F1 · derivative.expiration_date: (1) Each performance share converts into one share of common stock upon distribution during the first quarter of 2010. Read SEC document |
| March 02, 2008 Filed Mar 4, 2008 18:35 UTC | BRISTOL MYERS SQUIBB CO (BMY) · Entity 1662 | Tax withholdingCommon Stock, $0.10 par value | 1,178 | $22.61 | $26,634.58 |
DisclosureSEC source: 0000014272-08-000074 · hoo825.xml · nonDerivative · entry 2 HOOPER ANTHONY C · CIK 0001277244 · President US Pharmaceuticals 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,331 F1 · shares: Shares withheld for payment of taxes upon vesting of restricted stock. F2 · balance_after: Includes unvested restricted stock awards. Read SEC document |
| March 01, 2008 Filed Mar 4, 2008 18:35 UTC | BRISTOL MYERS SQUIBB CO (BMY) · Entity 1662 | Tax withholdingCommon Stock, $0.10 par value | 1,038 | $22.61 | $23,469.18 |
DisclosureSEC source: 0000014272-08-000074 · hoo825.xml · nonDerivative · entry 1 HOOPER ANTHONY C · CIK 0001277244 · President US Pharmaceuticals 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,509 F1 · shares: Shares withheld for payment of taxes upon vesting of restricted stock. F2 · balance_after: Includes unvested restricted stock awards. Read SEC document |
| September 10, 2007 Filed Sep 12, 2007 20:06 UTC | BRISTOL MYERS SQUIBB CO (BMY) · Entity 1662 | Tax withholdingCommon Stock, $0.10 par value | 3,871 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-07-000178 · hoo752.xml · nonDerivative · entry 1 HOOPER ANTHONY C · CIK 0001277244 · President US Pharmaceuticals 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 104,558 F1 · shares: Shares withheld for payment of taxes upon vesting of restricted stock. F2 · balance_after: Includes unvested restricted stock awards. Read SEC document |
| September 10, 2007 Filed Jan 15, 2008 22:05 UTC Amendment | BRISTOL MYERS SQUIBB CO (BMY) · Entity 1662 | Tax withholdingCommon Stock, $0.10 par value | 3,882 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-08-000020 · hoo776.xml · nonDerivative · entry 1 HOOPER ANTHONY C · CIK 0001277244 · President US Pharmaceuticals 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 104,547 F1 · shares: This form is being amended to correct the number of shares withheld for payment of taxes upon vesting of restricted stock. F2 · balance_after: Includes unvested restricted stock awards. Read SEC document |
| June 20, 2007 Filed Jun 21, 2007 19:09 UTC | BRISTOL MYERS SQUIBB CO (BMY) · Entity 1662 | Tax withholdingCommon Stock, $0.10 par value | 2,431 | $31.23 | $75,920.13 |
DisclosureSEC source: 0000014272-07-000151 · hoo737.xml · nonDerivative · entry 1 HOOPER ANTHONY C · CIK 0001277244 · President US Pharmaceuticals 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,549 F1 · shares: Shares withheld for payment of taxes upon vesting of restricted stock. F2 · balance_after: Includes unvested restricted stock awards. Read SEC document |
| May 30, 2007 Filed Jun 1, 2007 16:44 UTC | BRISTOL MYERS SQUIBB CO (BMY) · Entity 1662 | Exercise / conversionOption (right to buy) · Derivative | 30,000 | $30.12 Strike: $28.90 | $903,600.00 |
DisclosureSEC source: 0000014272-07-000147 · hoo735.xml · derivative · entry 6 HOOPER ANTHONY C · CIK 0001277244 · President US Pharmaceuticals 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $0.10 par value · 30,000 shares Expires 2007-06-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 30, 2007 Filed Jun 1, 2007 16:44 UTC | BRISTOL MYERS SQUIBB CO (BMY) · Entity 1662 | Tax withholdingCommon Stock, $0.10 par value | 443 | $30.12 | $13,343.16 |
DisclosureSEC source: 0000014272-07-000147 · hoo735.xml · nonDerivative · entry 3 HOOPER ANTHONY C · CIK 0001277244 · President US Pharmaceuticals 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,980 F2 · kind: Shares withheld for payment of taxes upon exercise of stock option. Read SEC document |
| May 30, 2007 Filed Jun 1, 2007 16:44 UTC | BRISTOL MYERS SQUIBB CO (BMY) · Entity 1662 | Tax withholdingCommon Stock, $0.10 par value | 28,785 | $30.12 | $867,004.20 |
DisclosureSEC source: 0000014272-07-000147 · hoo735.xml · nonDerivative · entry 2 HOOPER ANTHONY C · CIK 0001277244 · President US Pharmaceuticals 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,423 F1 · kind: Shares withheld for payment of exercise price. Read SEC document |
| May 30, 2007 Filed Jun 1, 2007 16:44 UTC | BRISTOL MYERS SQUIBB CO (BMY) · Entity 1662 | Exercise / conversionCommon Stock, $0.10 par value | 30,000 | $28.90 | $867,000.00 |
DisclosureSEC source: 0000014272-07-000147 · hoo735.xml · nonDerivative · entry 1 HOOPER ANTHONY C · CIK 0001277244 · President US Pharmaceuticals 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 127,208 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 20, 2006 Filed Jun 22, 2006 21:00 UTC | BRISTOL MYERS SQUIBB CO (BMY) · Entity 1662 | Tax withholdingCommon Stock, $0.10 par value | 2,431 | $25.48 | $61,941.88 |
DisclosureSEC source: 0000014272-06-000152 · hoo576.xml · nonDerivative · entry 1 HOOPER ANTHONY C · CIK 0001277244 · President US Pharmaceuticals 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 113,165 F1 · shares: Shares withheld for payment of taxes upon exercise of stock option. Read SEC document |
| June 20, 2006 Filed Jun 27, 2006 15:59 UTC Amendment | BRISTOL MYERS SQUIBB CO (BMY) · Entity 1662 | Tax withholdingCommon Stock, $0.10 par value | 2,431 | $25.48 | $61,941.88 |
DisclosureSEC source: 0000014272-06-000154 · hoo577.xml · nonDerivative · entry 1 HOOPER ANTHONY C · CIK 0001277244 · President US Pharmaceuticals 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 113,165 F1 · shares: Filing amended solely to reflect the following corrected footnote: Shares withheld for payment of taxes upon vesting of restricted stock. Read SEC document |
| March 07, 2006 Filed Mar 9, 2006 22:09 UTC | BRISTOL MYERS SQUIBB CO (BMY) · Entity 1662 | GrantExecutive Option (right to buy) · Derivative | 78,750 | $0.00 Strike: $22.73 | $0.00 |
DisclosureSEC source: 0000014272-06-000099 · hoo523.xml · derivative · entry 6 HOOPER ANTHONY C · CIK 0001277244 · President US Pharmaceuticals 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,750 Underlying: Common Stock, $0.10 par value · 78,750 shares Expires 2016-03-06 F5 · derivative.exercise_date: Option is not exercisable until the closing share price of common stock achieves a price of at least 15% above the option grant price and remains at that price for seven consecutive trading days. Option vests 25% of the shares annually, on a cumulative basis, commencing one year after the date of grant, but may not be exercised until the threshold is satisfied. Read SEC document |
| March 07, 2006 Filed Mar 9, 2006 22:09 UTC | BRISTOL MYERS SQUIBB CO (BMY) · Entity 1662 | Tax withholdingCommon Stock, $0.10 par value | 1,862 | $22.73 | $42,323.26 |
DisclosureSEC source: 0000014272-06-000099 · hoo523.xml · nonDerivative · entry 3 HOOPER ANTHONY C · CIK 0001277244 · President US Pharmaceuticals 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 115,596 F3 · shares: Shares withheld for payment of taxes. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.